• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Architect Progesterone Reagent

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
  Class 2 Device Recall Architect Progesterone Reagent see related information
Date Initiated by Firm March 31, 2003
Date Posted April 24, 2003
Recall Status1 Terminated 3 on August 19, 2003
Recall Number Z-0782-03
Recall Event ID 25904
Product Classification Radioimmunoassay, Progesterone - Product Code JLS
Product Architect Progesterone Reagent Kit; list 6C26-27 (100 tests) and 6C26-22 (400 tests); Abbott Diagnostics, a Division of Abbott Laboratories, Abbott Park, IL 60064
Code Information list 6C26-27, lot 95651M201 list 6C26-22, lots 95651M200, 95651M202 
Recalling Firm/
Abbott Laboratories HPD/ADD
100/200 Abbott Park Road
Abbott Park IL 60064
For Additional Information Contact Abbott Customer Support
Manufacturer Reason
for Recall
Lot gives lower specimen results compared to results generated with other lots.
FDA Determined
Cause 2
Action Recalled by telephone calls and follow-up letters dated 3/31/03. The accounts were informed of the depressed patient specimen results, and were requested to discontinue use and destroy any of the three affected lots found in inventory. The accounts were advised to notify physicians of the lower patient results observed with these lots and suggest review of the patient results to determine any impact on patient management.
Quantity in Commerce 368 kits
Distribution Nationwide, Canada, Columbia, England, Japan, Australia, New Zealand and Singapore
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.